Related Experiment Video
Updated: Jul 19, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Lepromatous leprosy: a review and case report
Eduardo Chimenos Küstner1, Montserrat Pascual Cruz, Cristina Pinol Dansis
1Facultad de Odontología, Universidad de Barcelona. 13598eck@comb.es
Leprosy, a chronic disease caused by Mycobacterium leprae, can manifest orally with nodules, ulcers, and tissue destruction, particularly in lepromatous forms. Diagnosis and treatment are challenging due to long duration and drug resistance.
Area of Science:
- Infectious Diseases
- Dermatology
- Oral Medicine
Background:
- Leprosy, a chronic granulomatous disease caused by Mycobacterium leprae, presents diverse clinical forms.
- Oral manifestations are common in lepromatous leprosy, affecting 20-60% of patients.
Observation:
- Oral lesions in leprosy include nodules (lepromas), necrosis, slow-healing ulcers, and tissue destruction.
- Lesions typically occur on the palate, uvula, tongue, lips, and gums, potentially leading to maxilla destruction and tooth loss.
Findings:
- Diagnosis relies on clinical suspicion, confirmed by bacteriological, histopathological analyses, and the lepromin test.
- Differential diagnosis is extensive, including autoimmune diseases, infections, and malignancies.
Implications:
- Treatment for leprosy is prolonged, multi-drug, and costly, posing challenges especially in developing countries.
- Emerging drug resistance necessitates exploring alternative treatments like quinolones and macrolides.
More Related Videos
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
Published on: July 15, 2011
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents